SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-243299
Filing Date
2022-09-13
Accepted
2022-09-13 08:01:32
Documents
13
Period of Report
2022-09-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d319544d8k.htm   iXBRL 8-K 24757
2 EX-99.1 d319544dex991.htm EX-99.1 15066
  Complete submission text file 0001193125-22-243299.txt   167600

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rxrx-20220913.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxrx-20220913_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxrx-20220913_pre.xml EX-101.PRE 11263
7 EXTRACTED XBRL INSTANCE DOCUMENT d319544d8k_htm.xml XML 3377
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 221239757
SIC: 2836 Biological Products, (No Diagnostic Substances)